Semax identity is confirmed with mass spectrometry, read against an average mass near 813.9. The separation must also pull apart the oxidised form, which sits 16 units heavier, and sequence evidence backs it up. That oxidised form is the impurity a weak certificate misses, because only the instruments can see it.
- Semax is C37H51N9O10S, average mass near 813.9, PubChem CID 9811102.
- Methionine sulfoxide sits 16 mass units heavier and is the characteristic impurity.
- The sulfoxide is more polar, so it elutes ahead of the parent on reversed-phase.
- Histidine makes retention time sensitive to mobile phase pH, so it varies between laboratories.
- Mass cannot distinguish stereoisomers; only chiral analysis can.
- The method list on a certificate defines which failures it was capable of detecting.
What does identity mean for a synthetic peptide?
In plain terms, the oxidised form is like a twin wearing a slightly heavier coat. It looks the same to the eye, and only a careful weigh-in tells the two apart.
That the molecule in the vial is the one the label names, established by evidence rather than assertion. For Semax that is a heptapeptide, the ACTH fragment 4-7 extended with Pro-Gly-Pro, molecular formula C37H51N9O10S, average mass near 813.9, cataloged as PubChem CID 9811102.
Identity and purity are different questions. A vial can hold the right molecule at poor purity, or the wrong molecule at excellent purity, and a certificate reporting one has answered half.
Strong identity evidence is layered. A single instrument agreeing with itself is one result wearing two hats, which is why good reports stack methods that look redundant until you ask what each could miss.
- Observed mass against an average near 813.9
- A species 16 units heavier means methionine sulfoxide
- RP-HPLC separation with the chromatogram attached
- The sulfoxide elutes ahead of the parent, sometimes only as a shoulder
- Retention time varies with buffer pH because of the histidine
- Fragmentation data for sequence order, where the report carries it
- Accession number confirmed at the issuing laboratory
What does the mass result confirm?
That the assembled molecule weighs what Semax weighs. Electrospray ionisation charges the molecule, the analyser reports mass-to-charge, and the deconvoluted result is compared with the expected value.
A match is strong evidence and not proof of sequence, because mass is a sum and different arrangements of the same residues weigh the same. That gap is why sequence-level evidence exists as a separate step.
What a mass result does eliminate efficiently is a whole class of synthesis failures: a missing residue, an extra one, a truncated chain, an unremoved protecting group. Each shifts the mass by an amount the instrument sees at a glance and no other method catches as cheaply.
Why does the oxidised form dominate this compound's identity work?
Because it is the impurity Semax actually generates. The N-terminal methionine oxidises to methionine sulfoxide, adding one oxygen and 16 mass units.
Sixteen is unambiguous to a mass spectrometer. It is also the reason a certificate for this peptide should print the observed mass rather than the words identity confirmed: the number lets a reader see whether a 16-heavier species is present and in what proportion, and the phrase lets them see nothing.
The oxidised molecule is not a contaminant that got in. It is the intended molecule after a reaction, which makes it harder to argue away and more useful as a measure of how the material has been handled since synthesis.
How does the separation resolve it?
By polarity. Reversed-phase HPLC retains hydrophobic molecules longer, and the sulfoxide is more polar than the parent, so oxidised Semax comes off the column earlier.
Where the column and gradient resolve the two well, the chromatogram shows a distinct small peak ahead of the main one. Where they do not, it shows a shoulder on the leading edge, and how that shoulder is integrated starts to move the reported purity figure.
This is the practical argument for insisting the chromatogram is attached rather than summarised. A purity percentage tells you nothing about whether the peak was clean or whether a decision was made about where one peak ended and another began.
Does the histidine affect the analysis?
It affects the separation more than the identification. Histidine carries an imidazole side chain whose charge state changes across the pH range where peptide separations are run, and charge affects retention.
The practical consequence is that retention time for this peptide is more sensitive to mobile phase pH than it would be for a peptide without an ionisable side chain in that range. Two laboratories using different buffers can report different retention times for identical material.
That is a reason retention time alone is weak identity evidence, and a specific one rather than a general caution. The mass does not move with buffer pH. The retention time does.
What sequence evidence should a strong report carry?
Tandem mass spectrometry, where the molecule is fragmented and the fragment masses read. The pattern constrains the order of residues rather than only their sum, which is the gap a single mass leaves open.
Amino acid analysis is the other route: the peptide is hydrolysed to its constituent residues and each is quantified, giving composition and an independent measure of peptide content by weight.
Neither appears on most research certificates. Their absence is a limit rather than a failure. A report with mass and purity has established a great deal, one that adds fragmentation has established more, and it is reasonable to ask which you are holding rather than assuming the stronger answer.
What does a mis-identified peptide look like?
Rarely like an obvious fake. The failures that matter are close relatives: the oxidised form described above, a chain truncated by one residue, a diastereomer with wrong stereochemistry at a single position, or genuinely correct material that is mostly salt by weight.
Stereochemistry is the hardest to catch. Two stereoisomers weigh exactly the same, so mass spectrometry cannot separate them at all, and only chiral analysis or a separation developed to resolve them shows the difference.
None of this makes certificates worthless. It makes the method list the thing to read, because the methods define which of these failures the document was capable of detecting in the first place.
Why does the salt form change what the numbers mean?
A synthetic peptide leaves preparative purification as a salt, usually trifluoroacetate or acetate after an exchange step, and the counterion travels into the vial with it.
For identity this changes nothing: the mass spectrometer reports the peptide, not the salt. For quantity it changes everything, because the balance weighs peptide plus counterion plus whatever water the powder has absorbed.
That is why net peptide content exists as a number separate from purity, and why a certificate naming its counterion is telling you something real about how the material was made. Identity and quantity are answered by different instruments and neither constrains the other.
What makes evidence orthogonal?
Two methods are orthogonal when they can fail independently. Retention time and peak area both come from one separation, so a problem with that separation moves both and their agreement proves little.
Retention time paired with mass spectrometry is genuinely different evidence, because a mass detector would not be fooled by the co-elution that misled the retention time.
For Semax the orthogonal set is: a separation that can resolve the sulfoxide, a mass detector that identifies what each peak is, and where the report carries it, fragmentation for sequence order. Each answers something the others cannot.
How do you check the report describes your vial?
Confirm the accession or verification number at the issuing laboratory rather than with the seller. The laboratory holds the record; a seller holds a copy of a document. If the number resolves to a different lot, a different product, or nothing, the analysis is not evidence about your material.
Then match the lot number on the report to the vial. Rigorous analysis counts for nothing if the document was attached to the wrong batch, and that mismatch is far more common than falsified results.
Reports for material supplied here resolve through the certificate verification page, and the sizes carried are on the Semax product record.
What should you ask a supplier about identity?
Three questions. What was the observed mass, as a number rather than a verdict. What proportion of the material was the 16-heavier oxidised species. And can the accession number be looked up at the issuing laboratory.
The second question is the one specific to this compound, and it is the one a thin certificate cannot answer. A supplier reporting only total purity has not measured, or has not disclosed, the impurity this peptide is most likely to carry.
How to read the rest of the document is covered in the certificate guide.
What is the regulatory position?
International guidance on analytical validation defines what makes an identity method fit for purpose: specificity, accuracy, precision, and a demonstration that the method distinguishes the target from what else might plausibly be present. That is why a named method beside each result is not decoration.
There is no FDA-approved product containing Semax and no United States pharmacopeial monograph defining an acceptable batch. The specification a lot is released against is the supplier's own, which raises rather than lowers the value of knowing which methods produced each number.
What a research certificate can honestly establish is what a named laboratory measured, on a named lot, by named methods.
FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.
What is Semax studied for?
Published research on Semax investigates the areas below, which is a different question from what Semax will do for anyone, a claim about a living system that nothing on this site is sold for.
What it is. A man-made peptide seven building blocks long, based on a fragment of ACTH.
What the research looks at. Animal research coming largely from a narrow set of research groups.
How it is thought to work. Built from a piece of adrenocorticotropic hormone with a short tail added for durability, and it does not carry the parent hormone’s effect on cortisol. How it works is not settled.
What is not established. No approved product in the United States and no official standard. As with Selank, the published record is concentrated and thinner than the volume of commercial writing suggests.
The full record, including the certificate for the lot in stock, is on the Semax product page.
Common questions
What mass should Semax show on a certificate?
Why does the oxidised form elute before the main peak?
Can mass spectrometry alone prove a peptide is correct?
Does the histidine in Semax affect the analysis?
What should I ask a supplier about Semax identity?
Published certificates for Semax
Every figure below is read from a report the laboratory issued for that lot; each page carries the PDF and the lab's own verification link.
More documentation guides
Sources
- PubChem Compound Summary for CID 9811102, Semax. The openable record giving the molecular formula C37H51N9O10S and the average mass near 813.9 that an identity result is read against.
- ICH Q2(R2), Validation of Analytical Procedures . Defines specificity, accuracy and precision for identity procedures, and is the basis for requiring that a certificate name the method behind each result.
- FDA guidance, Q6B Specifications: Test Procedures and Acceptance Criteria. Sets out how identity, purity and named degradation products are treated as separate attributes rather than one figure.
- Finnrick independent verification portal. Third-party lookup used to confirm a certificate resolves to the lot it claims to describe, rather than confirming a document with the seller who supplied it.
